Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2010

01-01-2010 | Letter to the Editor

Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [(18)F]-FDG positron emission tomography

Authors: C. Durant, B. Hervier, C. Ansquer, A. Masseau, M. Hamidou

Published in: Annals of Hematology | Issue 1/2010

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Espinoza G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21:309–313CrossRef
2.
Sahin M, Alanoglu G, Aksu O, Tunc SE, Kapucuiglu N, Yener M (2007) Hodgkin’s lymphoma initially presenting with polymyalgic symptoms: a case report. Mod Rheumatol 17:160–162CrossRefPubMed
3.
Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, Dobert N et al (2003) Paraneoplastic syndromes: detection of malignant tumors using [(18)F]-FDG-PET. Q J Nucl Med 47:85–89PubMed
4.
Rutherford GC, Dineen RA, O’Connor A (2007) Imaging in the investigation of paraneoplastic syndromes. Clin Radiol 62:1021–1035CrossRefPubMed
5.
Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR (2008) Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc 83:917–922CrossRefPubMed
Metadata
Title
Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [(18)F]-FDG positron emission tomography
Authors
C. Durant
B. Hervier
C. Ansquer
A. Masseau
M. Hamidou
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0779-6

Other articles of this Issue 1/2010

Annals of Hematology 1/2010 Go to the issue

Original Article

Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportionof transfused units, and clinical follow-up

Letter to the Editor

Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor

Original Article

Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21

Letter to the Editor

Peri-operative thrombosis prophylaxis in the Chinese versus Caucasian population

Letter to the Editor

Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression

Original Article

Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits